Entest Group Inc

[Snowie]

Thanks for the Observation about the ENTB Post

I feel that the biomed and med tech industries are on the cusp of a number of real breakthroughs when it comes to how we look at diseases and then how we treat them. It appears as if ENTB has the correct outlook on just how such medical conditions need to examined, which is what makes the company a real looker at present.

Because there'll be a cash influx from the government into the biomed research field, there'll be an opportunity for companies on the data collection and collation end of things to really make a mark because, once the so-called "grunt work" has been done, downstream costs are lower and companies like ENTB can profit (which still isn't illegal in America, after all on their labors.

At present, ENTB looks to still be bumping up against what many here are saying is its ceiling but the markets today, on the heels of the passage of "ObamaCare" (health care reform) are generally on an upward climb, especially the pharmas and the large health systems. Also, companies like ENTB can expect -- if they have an effective executive suite (and it looks like ENTB does) -- to work closely with government entities like the National Institutes for Health (NIH) and Centers for Disease Control (CDC).

I think that, mainly, this will be because a generic version of a bioinformatics program has many implications for research into communicable diseases such as malaria, tuberculosis and some of the really nasty viral diseases such as Ebola and Marburg virus.

At least, I'm hoping that the case because I've been in some parts of the world where a number of these kinds of diseases are rampant (not Ebola and Marburg, thank goodness) and if we can assemble a database of everything known about such diseases under one system we can better design effective treatments, therapies and even (hopefully) cures.

ENTB looks to be a real player in this end of the medical world, right now, which is why I'm of a positive mind about it.